IMPORTANT SAFETY INFORMATION You should not use Kogenate® FS if you are allergic to rodents (like mice and hamsters) or are allergic to any ingredients in Kogenate FS. Tell your healthcare provider if you have been told you have heart disease or… Continue reading below   Dear Community Member,   At Bayer, we are strongly committed to supporting the hemophilia A community. We know that maintaining access to hemophilia A treatment is extremely costly, and we’re here to help. We are now offering the Kogenate® FS, antihemophilic factor (recombinant) $0 Co-pay Program* regardless of income. Eligible patients can now receive up to $12,000 in co-pay assistance for their Kogenate FS therapy.   More than one person in a household can receive assistance, as long as they meet the program requirements.   Enrollment is fast and simple. Here’s what you have to do:     Call 1-800-288-8374 between 8:30 AM and 5:30 PM (ET) to connect with a Factor Solutions Case Specialist. Spanish-speaking Case Specialists are available.   * People with private, commercial health insurance may receive Kogenate FS co-pay or co-insurance assistance, based on eligibility requirements. The program is on a first-come, first-served basis. Financial support is available for up to 12 months. Eligible patients can re-enroll for additional 12-month courses. The program is not for patients receiving prescription reimbursement under any federal-, state-, or government-funded insurance programs, or where prohibited by law. All people who meet these criteria are encouraged to apply. Factor Solutions Co-pay Assistance Eligibility Criteria What is offered through the program? Patient Services, Inc. (PSI) will administer and determine eligibility for the Program to help Kogenate FS patients afford their co-pay/co-insurance expenses.   Kogenate FS patients are qualified to apply for the program* if: They have hemophilia A   They currently have private health insurance   Who is not eligible for assistance? Patients on public health insurance are not eligible for assistance at this time. This includes but is not limited to patients insured through Medicare, Medicaid, TriCare, DOD plans, the Pre-existing Condition Insurance Plan (PCIP), and high-risk plans associated with a PCIP   Patients enrolled in Bayer Assistance Programs   Once approved for assistance: Funds administered by PSI can only be used towards a patient’s co-pay/co-insurance expenses for Bayer’s Kogenate FS   As a condition of payment, patients and pharmacies must comply with all contractual obligations made with third-party payers and insurance companies, and must provide notice of any benefits received and the value of this program to all payers as required by law, contract, or otherwise   INDICATIONS   Kogenate® FS antihemophilic factor (recombinant), is a medicine used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A.   Kogenate FS is used to prevent or control bleeding in adults and children with hemophilia A. Your healthcare provider may give you Kogenate FS when you have surgery. Kogenate FS can reduce the number of bleeding episodes in adults and children when used regularly (prophylaxis). Kogenate FS can reduce the risk of joint damage in children without pre-existing joint damage when used regularly.   Kogenate FS is not used to treat von Willebrand disease.   IMPORTANT SAFETY INFORMATION   You should not use Kogenate FS if you are allergic to rodents (like mice and hamsters) or are allergic to any ingredients in Kogenate FS.   Tell your healthcare provider if you have been told you have heart disease or are at risk for heart disease.   You could have an allergic reaction to Kogenate FS. Call your healthcare provider right away and stop treatment if you get rash or hives, itching, tightness of the chest or throat, difficulty breathing, light-headed, dizziness, nausea or a decrease in blood pressure.   Your body can make antibodies, called “inhibitors,” against Kogenate FS, which may stop Kogenate FS from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to factor VIII.   Other common side effects of Kogenate FS are local injection site reactions (pain, swelling, irritation at infusion site) and infections from implanted injection device. Tell your healthcare provider about any side effect that bothers you or does not go away.   Call your healthcare provider right away if bleeding is not controlled after using Kogenate FS.   For important risk and use information, please see full Prescribing Information.   You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.   Please note this email is not monitored. If you would like to contact us, please visit our website.       Contact Us  |  Privacy Policy  |  Terms of Use   Bayer, the Bayer Cross, and Kogenate are registered trademarks of Bayer. © 2014 Bayer HealthCare Pharmaceuticals Inc. All rights reserved.  07/14  KN56005414   Bayer HealthCare Pharmaceuticals 100 Bayer Boulevard, P.O. Box 915 Whippany, NJ 07981-0915 1 (888) 606-3780